Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
75N93019F00131 TA02 TO9 Development of a Protocol, Clinical Trial Implementation, Closeout and Analysis of a Phase 2 Clinical Trial to Evaluate the Eficacy of rMenB+OMV NZ (Bexsero, GSK) in Preventing Neisseria Gonorrhoese Infection
Grant
Overview
Affiliation
Overview
Awarded By
National Institute of Allergy and Infectious Diseases/NIH/DHHS
Total Award Amount
6607057.00
Direct Costs
5828252.00
Sponsor Award Id
75N93019F00131-HHSN272201300012I
Affiliation
Contributor
Jeanne Marrazzo
Principal Investigator
Jodie Dionne
Investigator